Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir

• Gilles Darcis,
• Sophie Bouchat,
• Anna Kula,
• Benoit Van Driessche,
• Nadège Delacourt,
• Caroline Vanhulle,
• Stéphane De Wit,
• Olivier Rohr,
• Christine Rouzioux,
• Carine Van Lint

Affiliations

Gilles Darcis

Brussels University (ULB), Service of Molecular Virology, Molecular Biology Department, Gosselies, Belgium; Liege University Hospital, Infectious Diseases Service, Liège, Belgium

Sophie Bouchat

Brussels University (ULB), Service of Molecular Virology, Molecular Biology Department, Gosselies, Belgium

Anna Kula

Brussels University (ULB), Service of Molecular Virology, Molecular Biology Department, Gosselies, Belgium

Benoit Van Driessche

Brussels University (ULB), Service of Molecular Virology, Molecular Biology Department, Gosselies, Belgium

Nadège Delacourt

Brussels University (ULB), Service of Molecular Virology, Molecular Biology Department, Gosselies, Belgium

Caroline Vanhulle

Brussels University (ULB), Service of Molecular Virology, Molecular Biology Department, Gosselies, Belgium

Stéphane De Wit

Saint Pierre University Hospital, Infectious Diseases Service, Brussels, Belgium

Olivier Rohr

Strasbourg University, Parasitology and tropical pathologies Institute, Strasbourg, France; Strasbourg University, Louis Pasteur University Institute of Technology Schiltigheim, France

Christine Rouzioux

Necker-Enfants Malades Hospital, Paris-Descartes University, Virology, Paris, France

Carine Van Lint

Brussels University (ULB), Service of Molecular Virology, Molecular Biology Department, Gosselies, Belgium